AR103825A2 - Compuestos para uso terapéutico en seres humanos y/o animales superiores, procesos para su preparación, composición plaguicida, usos y método de control - Google Patents
Compuestos para uso terapéutico en seres humanos y/o animales superiores, procesos para su preparación, composición plaguicida, usos y método de controlInfo
- Publication number
- AR103825A2 AR103825A2 ARP160100542A ARP160100542A AR103825A2 AR 103825 A2 AR103825 A2 AR 103825A2 AR P160100542 A ARP160100542 A AR P160100542A AR P160100542 A ARP160100542 A AR P160100542A AR 103825 A2 AR103825 A2 AR 103825A2
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- aralkyl
- heterocyclyl
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000575 pesticide Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 125000000217 alkyl group Chemical group 0.000 abstract 13
- 125000000623 heterocyclic group Chemical group 0.000 abstract 13
- 125000003118 aryl group Chemical group 0.000 abstract 12
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 12
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 11
- 125000004415 heterocyclylalkyl group Chemical group 0.000 abstract 10
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000004043 oxo group Chemical group O=* 0.000 abstract 4
- 125000001188 haloalkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000879 imine group Chemical group 0.000 abstract 1
- DRZYUGQPUJJLDN-UHFFFAOYSA-N n-ethenyl-1h-pyrazol-5-amine Chemical class C=CNC1=CC=NN1 DRZYUGQPUJJLDN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical group O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Un compuesto, para uso terapéutico en seres humanos y/o animales superiores, que es un derivado de 5-(vinilamino)pirazol de fórmula (1) o una sal del mismo aceptable como plaguicida, donde W es =N-, =CH-, =CR⁶- o =C(NR⁷R⁸)-; R⁶ es halógeno o haloalquilo; R⁷ y R⁸ son, independientemente uno de otro, hidrógeno, alquilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo, o uno de R⁷ o R⁸ es -CO-R⁷ᵃ, -CO-O-R⁸ᵃ, -SO-R⁷ᵃ o -SO₂R⁷ᵃ, o R⁷ y R⁸ conjuntamente con el átomo de N unido a ellos, forman un anillo heterocíclico de cinco a siete miembros que opcionalmente contiene un átomo de oxígeno, azufre o nitrógeno adicional en el anillo, o R⁷ y R⁸ conjuntamente con el átomo de N unido a ellos, forman un grupo imina -N=CR⁷ᵇR⁸ᵇ o un grupo iminoéter -N=CR⁷ᵇ(OR⁸ᵇ); R⁷ᵃ y R⁸ᵃ son alquilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo; R⁷ᵇ es hidrógeno, alquilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo; R⁸ᵇ es alquilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo, dichos grupos R⁷, R⁸, R⁷ᵃ, R⁸ᵃ, R⁷ᵇ y R⁸ᵇ, independientemente unos de otros, están opcionalmente sustituidos con uno o más átomos de halógeno, grupos hidroxilo, oxo, ciano, nitro, alquilo, alcoxi, alquiltio, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo o con amino, que está opcionalmente sustituido con grupos alquilo, alquenilo, alquinilo, arilo o heteroarilo; R¹ es ciano; R² es alquilo o cicloalquilo, cuyo grupo R² está opcionalmente sustituido con uno o más átomos de halógeno, grupos hidroxilo, oxo, alquilo, alcoxi, alquiltio, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo; R³ es alquilo, alquenilo, alquinilo, cicloalquilo, arilo, heterociclilo, aralquilo, heterociclilalquilo, -CO-O-R⁹, -CO-R¹⁰, -SO-R¹¹, -SO₂-R¹²; R⁹, R¹⁰, R¹¹ y R¹² son alquilo, haloalquilo, alquenilo, alquinilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo, donde dichos grupos R³, R⁹, R¹⁰, R¹¹ y R¹² están opcionalmente sustituidos con uno o más átomos de halógeno, grupos hidroxilo, oxo, alquilo, alcoxi, alquiltio, cicloalquilo, arilo, heterociclilo o aralquilo; R⁴ es halógeno o -NR¹³R¹⁴; R¹³ y R¹⁴ son, independientemente uno de otro, hidrógeno, alquilo, alquenilo, alquinilo, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo, o R¹³ y R¹⁴ conjuntamente con el átomo de N unido a ellos, forman un anillo heterocíclico de cinco a siete miembros que opcionalmente contiene un átomo de oxígeno, azufre o nitrógeno adicional en el anillo, dichos grupos R¹³ y R¹⁴ están opcionalmente sustituidos con uno o más átomos de halógeno, grupos hidroxilo, oxo, alquilo, alcoxi, alquiltio, cicloalquilo, arilo, heterociclilo, aralquilo o heterociclilalquilo; R⁵ es haloalquilo, haloalcoxi, halógeno; y n es un número entero seleccionado entre 0, 1 o 2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04026768 | 2004-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103825A2 true AR103825A2 (es) | 2017-06-07 |
Family
ID=34927332
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104701A AR051762A1 (es) | 2004-11-11 | 2005-11-09 | Vinilamino pirazoles como pesticidas |
| ARP160100541A AR103824A2 (es) | 2004-11-11 | 2016-03-02 | Compuestos de pirazol, excluido su uso terapéutico en seres humanos y/o animales superiores, composiciones plaguicidas, usos y método de control |
| ARP160100542A AR103825A2 (es) | 2004-11-11 | 2016-03-02 | Compuestos para uso terapéutico en seres humanos y/o animales superiores, procesos para su preparación, composición plaguicida, usos y método de control |
| ARP160100543A AR103826A2 (es) | 2004-11-11 | 2016-03-02 | Compuestos para su uso terapéutico en seres humanos y/o animales superiores, composición plaguicida, usos y método de control |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104701A AR051762A1 (es) | 2004-11-11 | 2005-11-09 | Vinilamino pirazoles como pesticidas |
| ARP160100541A AR103824A2 (es) | 2004-11-11 | 2016-03-02 | Compuestos de pirazol, excluido su uso terapéutico en seres humanos y/o animales superiores, composiciones plaguicidas, usos y método de control |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100543A AR103826A2 (es) | 2004-11-11 | 2016-03-02 | Compuestos para su uso terapéutico en seres humanos y/o animales superiores, composición plaguicida, usos y método de control |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7678384B2 (es) |
| EP (1) | EP1814862B1 (es) |
| JP (1) | JP2008519777A (es) |
| AR (4) | AR051762A1 (es) |
| BR (1) | BRPI0517480B1 (es) |
| CA (1) | CA2586702C (es) |
| ES (1) | ES2444016T3 (es) |
| MX (1) | MX2007005617A (es) |
| TW (1) | TW200631943A (es) |
| WO (1) | WO2006050772A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9820977B2 (en) | 2008-10-03 | 2017-11-21 | Bayer Healthcare Llc | Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| US8264091B2 (en) * | 2009-09-21 | 2012-09-11 | Stats Chippac Ltd. | Integrated circuit packaging system with encapsulated via and method of manufacture thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3539844A1 (de) | 1985-11-09 | 1987-05-14 | Bayer Ag | Substituierte 5-amino-1-aryl-pyrazole |
| GB8713768D0 (en) | 1987-06-12 | 1987-07-15 | May & Baker Ltd | Compositions of matter |
| GB8531485D0 (en) | 1985-12-20 | 1986-02-05 | May & Baker Ltd | Compositions of matter |
| DE3606476A1 (de) * | 1986-02-28 | 1987-09-03 | Bayer Ag | 1-arylpyrazole |
| WO1996025401A1 (en) | 1995-02-17 | 1996-08-22 | Rhone-Poulenc Agrochimie | Pesticidal 1-arylpyrazoles |
| US5629335A (en) | 1995-04-07 | 1997-05-13 | Rhone-Poulenc Inc. | Pesticidal 1-arylpyrazole-3-carboximidothioic acid esters |
| DE19650197A1 (de) * | 1996-12-04 | 1998-06-10 | Bayer Ag | 3-Thiocarbamoylpyrazol-Derivate |
| ES2297867T3 (es) * | 1996-12-24 | 2008-05-01 | Merial Limited | 1-aril-pirazoles pesticidas. |
| DE19824487A1 (de) | 1998-06-02 | 1999-12-09 | Bayer Ag | Substituierte 3-Thiocarbamoylpyrazole |
-
2005
- 2005-09-27 JP JP2007540510A patent/JP2008519777A/ja active Pending
- 2005-09-27 ES ES05791711.4T patent/ES2444016T3/es active Active
- 2005-09-27 WO PCT/EP2005/010403 patent/WO2006050772A1/en not_active Ceased
- 2005-09-27 BR BRPI0517480A patent/BRPI0517480B1/pt not_active IP Right Cessation
- 2005-09-27 EP EP05791711.4A patent/EP1814862B1/en not_active Not-in-force
- 2005-09-27 CA CA2586702A patent/CA2586702C/en not_active Expired - Fee Related
- 2005-09-27 MX MX2007005617A patent/MX2007005617A/es active IP Right Grant
- 2005-11-09 AR ARP050104701A patent/AR051762A1/es active IP Right Grant
- 2005-11-09 TW TW094139317A patent/TW200631943A/zh unknown
-
2007
- 2007-05-11 US US11/747,293 patent/US7678384B2/en not_active Expired - Lifetime
-
2016
- 2016-03-02 AR ARP160100541A patent/AR103824A2/es unknown
- 2016-03-02 AR ARP160100542A patent/AR103825A2/es unknown
- 2016-03-02 AR ARP160100543A patent/AR103826A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2586702C (en) | 2013-01-15 |
| AR103824A2 (es) | 2017-06-07 |
| EP1814862A1 (en) | 2007-08-08 |
| US20080076802A1 (en) | 2008-03-27 |
| BRPI0517480B1 (pt) | 2019-09-03 |
| CA2586702A1 (en) | 2006-05-18 |
| JP2008519777A (ja) | 2008-06-12 |
| ES2444016T3 (es) | 2014-02-21 |
| EP1814862B1 (en) | 2014-01-15 |
| BRPI0517480A (pt) | 2008-10-07 |
| AR103826A2 (es) | 2017-06-07 |
| TW200631943A (en) | 2006-09-16 |
| MX2007005617A (es) | 2007-07-09 |
| AR051762A1 (es) | 2007-02-07 |
| US7678384B2 (en) | 2010-03-16 |
| WO2006050772A1 (en) | 2006-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR124687A2 (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas | |
| AR127309A2 (es) | Derivados de piridazinona | |
| AR122776A2 (es) | Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus métodos y usos | |
| AR088029A1 (es) | Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central | |
| AR113842A1 (es) | Derivados de tiazol microbiocidas | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| AR058139A1 (es) | Microbiocidas y fungicidas y metodos de control | |
| AR113965A1 (es) | Triazol azoles ciclohexil ácidos como antagonistas de lpa | |
| AR087196A1 (es) | Metodos plaguicidas que utilizan compuestos de 3-piridil tiazol sustituido y derivados para combatir las plagas de animales ii | |
| AR037736A1 (es) | Derivados de pirimidina como moduladores o inhibidores de la actividad del factor de crecimiento insulinico tipo 1 (igf-1r) | |
| AR070636A1 (es) | Derivados de piridina, composicion farmaceutica y uso terapeutico | |
| SV2009003170A (es) | Isoxazolinas insecticidas | |
| AR107249A1 (es) | Compuestos depsipeptídicos como anthelmínticos | |
| AR100886A1 (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| AR067663A1 (es) | Derivados heterociclicos de etiloxi amidas, composiciones que los comprenden y usos de los mismos en agricultura u horticultura, como agentes antifungicos. | |
| AR118247A1 (es) | Combinación de compuestos activos | |
| AR056511A1 (es) | Derivados de 2-aminopirimidinas, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por el receptor de histamina h4 | |
| AR118435A1 (es) | Compuestos de aza-benzotiofeno y aza-benzofurano como antihelmínticos | |
| AR100806A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| AR060593A1 (es) | 5-amido-2-carboxiamida-indoles | |
| AR091208A1 (es) | Derivados de piperidina | |
| AR100810A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| AR107397A1 (es) | Derivados de heterociclos bicíclicos condensados como pesticidas | |
| AR069813A1 (es) | Derivados de 2- amino-pirimidina, una composicion farmaceutica, un metodo de preparacion del compuesto y uso del mismo para preparar un medicamento | |
| CO2020012353A2 (es) | Compuestos de pirazol sustituidos con heteroarilo y uso farmacéutico de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |